Observation of Initial Procalcitonin and the Clinical Course of Patients With Acute Respiratory Tract Infections

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

702 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-12-31

Study Completion Date

2007-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Observation of the initial Procalcitonin values and the clinical course of consecutively included patients with Acute Respiratory Tract Infections at general medical practices in greater Hannover.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Antibiotics in Patients With Acute Respiratory Tract Infection With Procalcitonin as Parameter

NCT00688610

Respiratory Tract Infection

COMPLETED PHASE2

POCT PCT in Outpatient LRTI

NCT05380869

Antimicrobial Stewardship Exacerbation of Allergic Asthma Exacerbation Copd +2 more

COMPLETED NA

Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19

NCT04456075

SARS-CoV2 COVID

UNKNOWN

Fast Identification of Pathogen in the Setting of Pneumonia Using Multiplex PCR

NCT01858974

Acute Lower Respiratory Tract Infection Pneumonia

COMPLETED

Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections

NCT02171338

Pneumonia Acute Exacerbation of Chronic Obstructive Airways Disease

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary endpoint:

* initial Procalcitonin values of patients with Acute Respiratory Tract Infections

Secondary endpoints:

* correlation of initial Procalcitonin values to classify Acute Respiratory Tract Infections
* correlation of initial Procalcitonin values to subjective severity of Acute Respiratory Tract Infections
* correlation of initial Procalcitonin values to antibiotic- prescriptions
* correlation of initial Procalcitonin values to frequency of admission to hospital
* correlation of initial Procalcitonin values to frequency of referrals (radiology, pneumology)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Tract Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* written informed consent
* all types of respiratory tract infection according to investigator´s diagnosis

Exclusion Criteria

* pretreatment with antibiotics in the past 2 weeks
* portal hypertension
* Major surgeries or multiple trauma which require hospitalization, in previous 4 weeks
* Autoimmune disease and systemic diseases (lupus erythematodes, wegener´s disease)
* Peritoneal dialysis
* Acute treated or recently operated medullary c-cell-carcinoma, SCLC, carcinoid
* Other inflammatory diseases (e.g. urinary tract infection, pyelonephritis, pancreatitis

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No